HIMS - CIK 0001773751
The table below shows Hims & Hers Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $89.36M | $109.09M | $25.84M | $9.48M | -$19.40M | -$15.95M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$15.45M | -$32.80M | $13.04M | -$4.11M | $18.45M | -$163.32M |
| Dividends paid | - | - | - | - | - |
Hims & Hers Health, Inc. reported operating cash flow of $300.01M for fiscal year 2025. That is up 19.5% from $251.08M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$74.87M (FY 2019) to $300.01M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | $0.00 | $28.06M | $0.00 | $0.00 | $22.03M |
| Financing cash flow | -$77.88M | -$23.02M | -$30.31M | -$3.41M | -$22.53M | $239.94M |